Results 9,801-9,820 of 12,718 for speaker:Louise O'Reilly

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: Last week we were told that we would have information very quickly. Can Mr. McCallion give an indication as to when we will have that information?

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: That is what we were told last week.

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: I wish briefly to go back to one of the questions I asked regarding the first outsourcing that preceded the main outsourcing decision. I want to be really clear about what I want from Mr. McCallion, who promised to provide the information to us. I want to see all of the information about the original decision in 2007 to outsource 60,000 tests to Quest Laboratories.

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: That is for the 60,000 smears.

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: We are not talking about the same thing because we know that 60,000 tests were outsourced in 2007, before the ongoing outsourcing-----

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: They were outsourced by a man called Mr. Finn.

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: It was in theIrish Independent. It is not news. That information was published in the Irish Independentnewspaper last year. When the decision to outsource was taken in 2008, according to the Dáil record there were accredited laboratories in Beaumont Hospital, the Rotunda Hospital, the Royal College of Surgeons in Ireland, RCSI and St. James's Hospital. There was also an arrangement...

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: I ask Mr. McCallion to check whether that would have been the level of laboratory availability in 2008. I refer now to the minutes of the meeting between the Department, the National Cancer Control Programme, NCCP and the National Screening Service, NSS, of 3 August. On page four it says that the clinical audit is "ongoing" and that a total of 120 letters had been issued so far, with "no...

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: Issued to whom?

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: The letters were issued to clinicians with an instruction to them, presumably based on the template letters.

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: The instruction to them was not to disclose, was it not, Dr. O'Keeffe? Let us be very clear here. The instruction in the case of the deceased was to stick a note on her file but there was no instruction at all to disclose. In no way, shape or form was there an instruction to disclose in any of those template letters.

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: Time is very short. It is breathtaking that people come in here and defend those letters but best of luck with that. Of those 120 letters sent to clinicians, does the HSE have information on how many women were advised of their own history and their own results?

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: Nobody thought to follow that up. Everybody just thought it was happening.

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: When it says "no adverse reaction", there was clearly an expectation of some form of adverse reaction - as anyone would expect - because the HSE team was also busy at the time preparing a media strategy for potential adverse reaction. The witness has said that 120 letters had been issued with no adverse reaction. Did nobody think that might have been because the information was not getting...

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: Was a flag not raised when 120 letters went out and there was no adverse reaction, as recorded in the minutes? Much of what we are discussing here has to do with us looking at information that should have had a red flag. The HSE team seemed completely unconcerned. Now, that HSE team seems concerned with apologising and telling us that with hindsight it would, of course, have been...

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: That just really underlines the need for mandatory disclosure and legislation for that.

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: Maybe Dr. Holohan can share it with the committee.

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: Yes, I am shocked. Can the witnesses explain the difference between urgent and non-urgent cases? I am looking through the minutes and I see that some referrals are urgent and some are non-urgent. The reason I ask is that I have been contacted by several people who tell me that they experienced symptoms following a smear test that did not show up anything. I will not get into a...

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: No. It is related to the urgent and non-urgent categories, as they apply to women who have had symptoms of cervical cancer in the immediate aftermath of several negative smear tests.

Joint Oireachtas Committee on Health: CervicalCheck Screening Programme: Discussion (16 May 2018)

Louise O'Reilly: They are not being seen urgently. Could Dr. McKenna comment on that? They are being referred to as non-urgent.